These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9477222)

  • 1. Change in the mode of inhibition of acetylcholinesterase by (4-nitrophenyl)sulfonoxyl derivatives of conformationally constrained choline analogues.
    Savle PS; Medhekar RA; Kelley EL; May JG; Watkins SF; Fronczek FR; Quinn DM; Gandour RD
    Chem Res Toxicol; 1998 Jan; 11(1):19-25. PubMed ID: 9477222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of acetylcholinesterase by hemicholiniums, conformationally constrained choline analogues. Evaluation of aryl and alkyl substituents. Comparisons with choline and (3-hydroxyphenyl)trimethylammonium.
    Lee BH; Stelly TC; Colucci WJ; Garcia JG; Gandour RD; Quinn DM
    Chem Res Toxicol; 1992; 5(3):411-8. PubMed ID: 1504265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and study of thiocarbonate derivatives of choline as potential inhibitors of acetylcholinesterase.
    Boyle NA; Talesa V; Giovannini E; Rosi G; Norton SJ
    J Med Chem; 1997 Sep; 40(19):3009-13. PubMed ID: 9301662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.
    Bolognesi ML; Bartolini M; Cavalli A; Andrisano V; Rosini M; Minarini A; Melchiorre C
    J Med Chem; 2004 Nov; 47(24):5945-52. PubMed ID: 15537349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha,beta-Dehydrophenylalanine choline esters, a new class of reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase.
    Grigoryan HA; Hambardzumyan AA; Mkrtchyan MV; Topuzyan VO; Halebyan GP; Asatryan RS
    Chem Biol Interact; 2008 Jan; 171(1):108-16. PubMed ID: 17980356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzene-1,2-, 1,3-, and 1,4-di-N-substituted carbamates as conformationally constrained inhibitors of acetylcholinesterase.
    Lin MC; Hwang MT; Chang HG; Lin CS; Lin G
    J Biochem Mol Toxicol; 2007; 21(6):348-53. PubMed ID: 17994573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic evidence for different mechanisms of acetylcholinesterase inhibition by (1R)- and (1S)-stereoisomers of isomalathion.
    Jianmongkol S; Marable BR; Berkman CE; Talley TT; Thompson CM; Richardson RJ
    Toxicol Appl Pharmacol; 1999 Feb; 155(1):43-53. PubMed ID: 10036217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of acetylcholinesterase by 14 achiral and five chiral imidazole derivates.
    Kovárová M; Komers K; Stepánková S; Cegan A
    Bioresour Technol; 2010 Aug; 101(15):6281-3. PubMed ID: 20335028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticholinergic activities of D(-)R- and L(+)S-mandeloylcholines.
    Cheng HC; Sastry BV
    Arch Int Pharmacodyn Ther; 1976 Oct; 223(2):246-59. PubMed ID: 999408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein ligand interactions: alkylated pyridinium salts as inhibitors of acetylcholinesterase from Electrophorus electricus.
    Whiteley CG; Ngwenya DS
    Biochem Biophys Res Commun; 1995 Jun; 211(3):1083-90. PubMed ID: 7598696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
    Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
    J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminopyridazines as acetylcholinesterase inhibitors.
    Contreras JM; Rival YM; Chayer S; Bourguignon JJ; Wermuth CG
    J Med Chem; 1999 Feb; 42(4):730-41. PubMed ID: 10052979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of functionalized coumarins as acetylcholinesterase inhibitors.
    Shen Q; Peng Q; Shao J; Liu X; Huang Z; Pu X; Ma L; Li YM; Chan AS; Gu L
    Eur J Med Chem; 2005 Dec; 40(12):1307-15. PubMed ID: 16182411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choline availability and acetylcholine synthesis in the hippocampus of acetylcholinesterase-deficient mice.
    Hartmann J; Kiewert C; Duysen EG; Lockridge O; Klein J
    Neurochem Int; 2008 May; 52(6):972-8. PubMed ID: 18023504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of enantiomers of exo-2-norbornyl-N-n-butylcarbamate and endo-2-norbornyl-N-n-butylcarbamate for stereoselective inhibition of acetylcholinesterase.
    Chiou SY; Huang CF; Yeh SJ; Chen IR; Lin G
    Chirality; 2010 Feb; 22(2):267-74. PubMed ID: 19496158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and evaluation of isaindigotone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Pan L; Tan JH; Hou JQ; Huang SL; Gu LQ; Huang ZS
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3790-3. PubMed ID: 18524585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcholinesterase inhibition by pitofenone: a spasmolytic compound.
    Punekar NS; Kulkarni AV
    Biotechnol Appl Biochem; 1991 Dec; 14(3):378-82. PubMed ID: 1777122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
    Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
    Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
    Camps P; El Achab R; Görbig DM; Morral J; Muñoz-Torrero D; Badia A; Eladi Baños J; Vivas NM; Barril X; Orozco M; Luque FJ
    J Med Chem; 1999 Aug; 42(17):3227-42. PubMed ID: 10464010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
    Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
    Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.